Pharmabiz1h
Paratek Pharma announces positive top-line data from phase 2b study of oral omadacycline in NTM abscessus pulmonary disease
Paratek Pharma announces positive top-line data from phase 2b study of oral omadacycline in NTM abscessus pulmonary disease: Boston Monday, November 11, 2024, 18:00 Hrs [IST] Para ...
Pharmabiz2h
Harbour BioMed submits IND application for HBM9378/SKB378 to China NMPA to treat chronic obstructive pulmonary disease
Harbour BioMed submits IND application for HBM9378/SKB378 to China NMPA to treat chronic obstructive pulmonary disease: Suzhou, China Monday, November 11, 2024, 17:00 Hrs [IST] Ha ...
Pharmabiz2h
UDF to organize experts meeting towards creation of Indian Pharmaceutical Regulatory Service cadre
New Delhi based NGO Udyog Development Foundation (UDF) has called for an experts meeting themed “India Pharmacists' Adhiveshan” towards creation of regulatory service cadre in the pharma sector for ...
Pharmabiz2h
Dr Jayachandra Babu Ramapuram receives 2024 AAPS Fellow Award
Dr Jayachandra Babu Ramapuram has been honoured with the prestigious AAPS Fellow Award at the American Association of Pharmaceutical Scientists (AAPS) annual meeting held in Salt Lake City, Utah. This ...
Pharmabiz11h
Ayush and herbal products exports grow over 10 per cent in H1 FY25
Exports of Ayush and herbal products for the first six months of the current fiscal has reported a 10.34 per cent growth, as ...
Pharmabiz4h
Leucine Rich Bio unveils #HappyGutMission campaign, survey indicates 29.7% individuals report frequent antibiotic use
Leucine Rich Bio, now unveils its #HappyGutMission campaign an initiative designed to educate people on the critical role of gut health. This campaign has brought gut health to the forefront, offering ...
Pharmabiz4h
US FDA advisory panel votes in favour of IceCure's ProSense cryoablation benefit-risk profile in early-stage low risk breast cancer
US FDA advisory panel votes in favour of IceCure's ProSense cryoablation benefit-risk profile in early-stage low risk breast cancer: Caesarea, Israel Monday, November 11, 2024, 15 ...
Pharmabiz3h
Robles BioCeutics collaborates with BioCentrium to explore the molecular mechanisms behind Glowselle stem cell activator
Robles BioCeutics LLC, a regenerative dermatology company, announced a new collaboration with BioCentrium aimed at advancing research into the molecular mechanisms behind its patent-pending Glowselle ...
Pharmabiz3h
EMA’s veterinary committee issues first certificate for vaccine platform technology master file
EMA's Committee for Veterinary Medicinal Products (CVMP) has issued the first certificate for a vaccine platform technology master file (vPTMF) which will support and accelerate the development and ...
Pharmabiz4h
US FDA clears SystImmune’s IND application for BL-M17D1 in advanced solid tumours
SystImmune, Inc (SystImmune), a clinical-stage biotechnology company, announced that the US Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for BL-M17D1, ...
Pharmabiz4h
Quantiphi and DDReg partner to transform regulatory reporting in life sciences through AI
Quantiphi and DDReg partner to transform regulatory reporting in life sciences through AI: Our Bureau, Bengaluru Monday, November 11, 2024, 13:45 Hrs [IST] Quantiphi, a global AI- ...
Pharmabiz2h
Johnson & Johnson seeks US & EU approvals for Darzalex Faspro/Darzalex as subcutaneous monotherapy for high-risk smoldering multiple myeloma
Johnson & Johnson announced the submission of regulatory applications to the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) seeking approval of a new indication for Darzalex ...